I staggered out of my Uber into a sea of orange. My next challenge—a monolithic 100,119-seat stadium—loomed in the distance.…
Investing
Medicare’s decades-old exclusion of weight-loss drug coverage is coming under scrutiny amid mounting evidence that Wegovy and similar medications have…
Today I want to show you three funds that are highly unusual in a way that matters a lot to…
Bitcoin and other cryptocurrencies rose Monday amid continued optimism over the approval of exchange-traded funds, with recent buoyancy across a…
The Federal Reserve is expected to ultimately cut interest rates in 2024, but in a measured way and with action…
Every year around this time, the giant Baltimore-based investment shop T. Rowe Price Group TROW sends investment managers and strategists…
The holidays can be both a source of joy and stress for many, but none so much as a family…
News that hundreds of OpenAI staff are threatening to leave in the wake of Sam Altman’s shock ouster from the…
The November 13th cover of Barron’s highlighted the crash in green stocks. The cover pointed out that renewable energy equities…
The U.S. initial public offering calendar is empty this holiday-shortened week, but some recent additions to the pipeline suggest December…